SCHEMBL8806402

SCHEMBL8806402

Nc1ccc([N+](=O)[O-])c(NCCc2c(Cc3ccc(F)cc3)[nH]c3ccccc23)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
HPGD P15428 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP2C9 P11712 1/20 0.42
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP19A1 P11511 2/20 0.38
PRKCQ Q04759 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8805765 0.87 TXNRD1 (0.43) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL9054192 0.73 ALDH1A1 (0.46) CYP3A4CYP2C19MEN1KMT2APOLB
SCHEMBL8816712 0.71 MEN1 (0.47) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL8804608 0.70 CYP1A2 (0.46) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL8805489 0.70 CYP1A2 (0.45) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL8806339 0.69 CYP1A2 (0.44) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL8805387 0.67 MTNR1A (0.48) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL7853508 0.66 MAPT (0.58) HPGDMEN1KMT2APOLBMAPT
SCHEMBL8805180 0.64 KCNQ2 (0.58) TDP1CYP1A2CYP3A4HPGDTSHR
SCHEMBL8805163 0.63 EGFR (0.53) TDP1CYP1A2CYP3A4HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0775131-A2 INDOL, INDAZOL, PYRIDOPYRROL AND PYRIDOPYRAZOL DERIVATIVES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY AND IMMUNOMODULATING EFFECTS ASTA Medica Aktiengesellschaft (DE) 1997-05-28 EP disclosed